Roussos-Torres and colleagues perform a phase Ib clinical trial of entinostat, nivolumab and ipilimumab in individuals with advanced HER2-negative breast cancer, report on safety and response and characterize the immune-modulatory effects.
- Evanthia.T. Roussos Torres
- Won J. Ho
- Roisin M. Connolly